Data from the J.D. Power 2025 U.S. Healthcare Digital Experience Study revealed that health insurance members enrolled in health plans and Medicare Advantage plans use their plan websites and mobile apps as their primary means of communication, but the quality of these digital experiences lags behind that of other industries.  In the study, Cigna Healthcare […]

Coreline Soft announces first China partnership South Korean medical AI company Coreline Soft has entered into its first partnership in China.  It signed a memorandum of understanding with Suhai Information Technology, which reportedly runs a network of medical institutions in China. Coreline Soft will tap into this network to collect clinical data, which will help tailor its AI

Specialty pharmaceutical distributor Morris & Dickson is partnering with Mark Cuban’s Cost Plus Drug Company (MCCPDC) and the Cost Plus Marketplace to ensure access to vital injectable medications. MCCPDC offers consumers a broad range of low-cost prescription and over-the-counter drugs from National Association of Boards of Pharmacy (NABP) accredited suppliers.  The Cost Plus Marketplace gives

hellocare.ai, which offers AI-enabled virtual care delivery for smart hospital rooms, has secured $47 million in an oversubscribed funding growth round.  HealthQuest Capital led the round with participation from several health systems and digital health investors, including UCHealth, Bon Secours Mercy Health, LRVHealth and OSF Ventures.  WHAT IT DOES The Florida-based company provides a virtual

Digital therapeutic company Click Therapeutics was granted FDA marketing authorization for its prescription digital therapeutic for the preventive treatment of episodic migraines. The de novo classification is for the company’s CT-132 offering, which it received FDA Breakthrough Device Designation for in 2022. CT-132 is intended for the preventive treatment of episodic migraine in patients 18

Phantom Neuro, a neurotechnology company that offers a muscle machine interface for controlling prosthetic limbs and robotic exoskeletons, announced an oversubscribed $19 million Series A funding round, bringing its total raise to $28 million. Ottobock led the round with participation from existing investors Draper Associates, Time BioVentures, Breakout Ventures, Risk and Return, LionBird Ventures and

Glucose monitoring specialist Dexcom announced it received FDA clearance for its G7 15 Day continuous glucose monitoring (CGM) system for people 18 and older with type 1, type 2 and gestational diabetes.  G7 15 Day, scheduled to launch in the second half of this year, will have a 15.5-day wear time (including a 12-hour grace

The White House Office of Management and Budget (OMB) released two memos directed to the heads of all executive branch departments and agencies establishing policies on federal AI use and purchase of AI in government.  The memos, which align with an Executive Order President Donald Trump signed in January, replace Biden’s previous guidance (M-24-10 and

Research from Japan has demonstrated the use of eye-tracking technology in the early diagnosis of autism spectrum disorder. Waseda University associate professor Mikimasa Omori set out to examine whether children with potential ASD would exhibit a preference for predictable movement – a behaviour indicative of the neurodevelopmental disorders – longer than typically developing children. FINDINGS

According to a study published in the European Journal of Cancer, the fairness and equity of datasets for AI-driven mammogram interpretation might be jeopardized by the underrepresentation of racial and ethnic diversity. While AI shows promise for enhancing how mammograms are interpreted, particularly in areas where resources are limited, the study’s authors found warning signs